Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Monika Tomaszewska-Kiecana, Anna Dryja, Martin Ullmann, Corinne Petit-Frere, Andras Illes, Christos Dagres & Joëlle Monnet. (2023) Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults. Expert Review of Clinical Immunology 19:4, pages 447-455.
Read now
Read now
Ismael García-Moguel, Ana Rosado, Aída Gómez-Cardeñosa, Mar Gandolfo-Cano, Teresa Robledo Echarren, Maria del Mar Moro Moro, Mª del Mar Reaño Martos, Rafael Pineda-Pineda, Marcela Valverde-Monge, Cristina Martin-Arriscado Arroba & Javier Domínguez-Ortega. (2022) Reliability, Satisfaction and Effectiveness of Benralizumab Home Self-Administration in Patients with Severe Eosinophilic Asthma in Real-World Practice: The Auto-Benra Study. Journal of Asthma and Allergy 15, pages 623-632.
Read now
Read now
Ronak Patel, Pravin Ghadge, Pravin A. Nair, Manish Kumar & Laxmi Adhikary. (2022) A review of bridging clinical studies between different presentations of biological products approved by the United States Food and Drug Administration (US FDA). Expert Opinion on Biological Therapy 22:10, pages 1293-1310.
Read now
Read now
Michelle Dilley Revier & Bob Geng. (2022) Mepolizumab prefilled syringe for the treatment of severe eosinophilic asthma: focus on the pediatric population. Expert Review of Respiratory Medicine 16:8, pages 857-865.
Read now
Read now
Jakob Lange, Andreas Schneider, Christoph Jordi, Michael Lau & Timothy Disher. (2021) Formative Study on the Wearability and Usability of a Large-Volume Patch Injector. Medical Devices: Evidence and Research 14, pages 363-377.
Read now
Read now
Ubaldo J. Martin, Rainard Fuhr, Pablo Forte, Peter Barker, Milton J. Axley, Magnus Aurivillius, Li Yan & Lorin Roskos. (2021) Comparison of autoinjector with accessorized prefilled syringe for benralizumab pharmacokinetic exposure: AMES trial results. Journal of Asthma 58:1, pages 93-101.
Read now
Read now
Lanfranco Pellesi, Roberto De Icco, Mohammad Al-Mahdi Al-Karagholi & Messoud Ashina. (2020) Reducing Episodic Cluster Headaches: Focus on Galcanezumab. Journal of Pain Research 13, pages 1591-1599.
Read now
Read now
Zhongwang Dou, Javad Eshraghi, Tianqi Guo, Jean-Christophe Veilleux, Kevin H. Duffy, Galen H. Shi, David S. Collins, Arezoo M. Ardekani & Pavlos P. Vlachos. (2020) Performance characterization of spring actuated autoinjector devices for Emgality and Aimovig. Current Medical Research and Opinion 36:8, pages 1343-1354.
Read now
Read now
Chiara Lupi, Simona Guerzoni, Andrea Negro & Silvia Benemei. (2019) Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapy. Therapeutics and Clinical Risk Management 15, pages 557-569.
Read now
Read now
Gary T Ferguson, Jeremy Cole, Magnus Aurivillius, Paul Roussel, Peter Barker & Ubaldo J Martin. (2019) Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results. Journal of Asthma and Allergy 12, pages 363-373.
Read now
Read now
Articles from other publishers (9)
Alba López‐Bravo, Antonio Oliveros‐Cid & Laura Sevillano‐Orte. (2022) Treatment satisfaction with calcitonin gene‐related peptide monoclonal antibodies as a new patient‐reported outcome measure: A real‐life experience in migraine. Acta Neurologica Scandinavica 145:6, pages 669-675.
Crossref
Crossref
Jaein Seo, Charlie A. Smith, Caitlin Thomas, Tommi Tervonen, Asha Hareendran, Janet H. Ford, Virginia L. Stauffer, Robert A. Nicholson, Kevin Harrison Duffy & Antje Tockhorn-Heidenreich. (2021) Patient Perspectives and Experiences of Preventive Treatments and Self-Injectable Devices for Migraine: A Focus Group Study. The Patient - Patient-Centered Outcomes Research 15:1, pages 93-108.
Crossref
Crossref
Irina Cherniakov, Orit Cohen‐Barak, Ryan Tiver, Michael Gillespie, Yoel Kessler, Maria Gutierrez, Michele Rasamoelisolo, Shawn Li, Honglue Shen, Hussein Hallak, Pippa S. Loupe, Michael Smith, Laura Rabinovich‐Guilatt & Ofer Spiegelstein. (2021) A Pharmacokinetic Bioequivalence Study of Fremanezumab Administered Subcutaneously Using an Autoinjector and a Prefilled Syringe. Clinical Pharmacology in Drug Development 10:9, pages 1018-1027.
Crossref
Crossref
Virginia L. Stauffer, Shufang Wang, Jo Bonner, ByungKun Kim, Rohit Bhandari, Kathleen A. Day & Angelo Camporeale. (2020) Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraine. BMC Neurology 20:1.
Crossref
Crossref
Anja St Clair-Jones, Francesca Prignano, Joao Goncalves, Muriel Paul & Philipp Sewerin. (2020) Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review. Rheumatology and Therapy 7:4, pages 741-757.
Crossref
Crossref
Lesley J. Scott. (2020) Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache. Drugs 80:9, pages 893-904.
Crossref
Crossref
William Kielbasa & Tonya Quinlan. (2019) Population Pharmacokinetics of Galcanezumab, an Anti‐CGRP Antibody, Following Subcutaneous Dosing to Healthy Individuals and Patients With Migraine. The Journal of Clinical Pharmacology 60:2, pages 229-239.
Crossref
Crossref
Sandeep Choudhary, Gaurav Pandey, Rupsha Mukherjee & Abhijeet Joshi. 2019. Biomedical Engineering and its Applications in Healthcare. Biomedical Engineering and its Applications in Healthcare
297
326
.
Stewart J. Tepper. (2018) Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018. Headache: The Journal of Head and Face Pain 58, pages 276-290.
Crossref
Crossref